Navigation Links
Actor Rob Brown Rushes to Gain Ground Against Blood Cancer
Date:3/3/2008

Star of Upcoming Universal Pictures' Drama The Express Named National Spokesperson for The Leukemia & Lymphoma Society's 2008 Light The Night

Walk

WHITE PLAINS, N.Y., March 3 /PRNewswire/ -- Rob Brown, who stars in the upcoming drama The Express as Ernie Davis, a 1960s football hero who battled leukemia and became the first African-American to win the Heisman Trophy, is the national spokesperson for The Leukemia & Lymphoma Society's (LLS) 2008 Light The Night(R) Walk, an annual event that raises critical funds for research and patient services, and honors lives touched by blood cancer. The film is scheduled for release on Oct. 3, 2008.

Raised in poverty in Pennsylvania coal-mining country, Davis overcame seemingly insurmountable obstacles to become an unstoppable running back for the Syracuse University Orangemen. Following his draft to play for the Cleveland Browns, tragedy struck the athlete and he was never able to take the professional field. In 1963, Davis died of leukemia, but his legacy of smashing barriers on and off the playing field lives on.

"Ernie Davis's dreams were cut short by leukemia at the age of 23," said Brown. "Playing the role of Davis has helped me understand that all blood cancer patients deserve to live better, longer lives and that supporting research to help make cures happen is crucial."

As national spokesperson for the 2008 Walk, Brown has filmed a public service announcement and lent his image to brochures, posters and other publicity materials. Brown earned renown for his starring role in the 2000 film Finding Forrester. He will next appear in March's Stop Loss, a drama about young soldiers who return to Texas after fighting in Iraq.

"Rob Brown is an outstanding role model and a compassionate spokesperson for our cause," said Nancy Klein, senior vice president, LLS Marketing Communications. "His involvement with Light The Night and The Express will go a long way toward raising awareness about the urgency of finding cures and better treatments."

Light the Night Walk events are taking place in your community. For more information about Light The Night, please visit http://www.lightthenight.org.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the LLS has invested more than $550 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit http://www.LLS.org or call the LLS Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact: Andrea Greif

914-821-8958

andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic Factors for Smoking Boost Chronic Bronchitis Risk
2. Genetic factors in smoking also increase risk of chronic bronchitis
3. Effect of tumor necrosis factor a inhibitors on heart failure risk in RA Patients
4. NIH awards OHSU researcher $1.2 million to determine causes of, risk factors for pelvic floor injury
5. More Risk Factors, Less Access to Care Behind Higher Stroke Rates in U.S.
6. Stroke Risk Factors Drain Memory
7. Hormone refractory prostate cancers more likely to spread to other organs
8. TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States
9. Arizona State bioethicist says mental illness is subject to biological and sociocultural factors
10. PTSD a Risk Factor for Long-Term Disease
11. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology: